Arlenda nominated 3 years in a row among the fastest growing technologies company : ranked 39th Thanks to a noticeable growth of 112% since 2014, Arlenda was nominated for the third time by Deloitte among the FAST50 high tech companies in Belgium. This year, Arlenda...

Strong presence of Arlenda at BAYES2016 in Leuven, Belgium on May 17-20 th, 2016. Arlenda’s scientists were selected to present 4 talks and 1 poster, reflecting the recognized expertise of Arlenda in applied Bayesian statistics for pharmaceutical industry. The talks...

ARLENDA RANKED 26TH AMONG THE 50 FASTEST GROWING COMPANIES IN BELGIUM Thanks to a growth rate of 99% between 2011 and 2014, we succeeded in being ranked 26th among the 50 fastest-growing technology companies in Belgium. Last year, Arlenda was ranked as the 25th...

SEELVA 2.0: Arlenda's Answer to the Validation of Bioassays To remain competitive in today's demanding business landscape, you need all parts of your operation working together at maximum efficiency. This is why Seelva V2.0, the intuitive web-application developed by...

Looking back on the Software Day Last March, Arlenda organized a full day focused on new regulatory requirements for statistics and the evolution of its software. Among the 30 participants, most were current users but some were companies looking for new opportunities...

FOCUS OF THE MONTH Don't delay signing up for our next Software day organized in partnership with Qualilab. Join us on March 17th in Paris and discover what's new about our software and meet other users. You will find all the information about the event on our...

WHAT’S NEW E.NOVAL AND SEELVA ALLOW TO ACHIEVE UPCOMING USP RECOMMENDATIONS ON VALIDATION OF ANALYTICAL PROCEDURES At the recent USP Workshop on Lifecycle Approach to Validation of Analytical Procedures with Related Statistical Tools held in Rockville (MD, USA) on...

We are proud to announce that version 3.0 of our software Stab.e.lity has been released! Analyse your stability data and generate reports in only a few seconds. It's accurate, flexible and compliant with authority requirements (FDA, ICH, GAMP 5, 21 CFR part 11, etc)....